Cure My Disease

Don't miss your cure!

 Log in / Sign up

New gut bacteria therapy shows promise for colitis

NCT ID NCT06582264

Completed Disease control Sponsor: Microbiotica Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a new treatment called MB310 in 29 adults with mild-to-moderate ulcerative colitis. The main goal was to see if it is safe and how well it takes hold in the body. Participants received either MB310 or a placebo, and researchers monitored side effects and signs of disease control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ULCERATIVE COLITIS

Contacts and locations

Locations

  • Acibadem City Clinic, Tokuda Hospital

    Sofia, Bulgaria

  • Addenbrooke's Hospital

    Cambridge, United Kingdom

  • Centro Medico Teknon

    Barcelona, Spain

  • Centrum Medyczne Kermed

    Bydgoszcz, Poland

  • Corporacio Sanitaria Parc Tauli - Hospital de Sabadell

    Sabadell, Spain

  • Diagnostic Consulting Center Convex EOOD

    Sofia, Bulgaria

  • Diagnostic-Consulting Center

    Varna, Bulgaria

  • Hospital Alvaro Cunqueiro

    Vigo, Spain

  • Hospital Clinico Universitario de Santiago

    Santiago de Compostela, Spain

  • Hospital Universitario Juan Ramon Jimenez

    Huelva, Spain

  • Klinikum Klagenfurt am Woerthersee

    Klagenfurt, Austria

  • Korczowski Bartosz, Gabinet Lekarski

    Rzeszów, Poland

  • Medical Center Rusemed EOOD

    Sofia, Bulgaria

  • Medizinische Universitaet Innsbruck

    Innsbruck, Austria

  • Medizinische Universitaet Wien

    Vienna, Austria

  • Panstwowy Instytut Medyczny MSWiA - Klinika Gastroenterologi i Chorob Wewnetrznych

    Warsaw, Poland

  • St George's Hospital

    London, United Kingdom

  • Uniklinikum Salzburg

    Salzburg, Austria

  • University Hospital Birmingham

    Birmingham, United Kingdom

  • University Multiprofile Hospital for Active Treatment

    Stara Zagora, Bulgaria

  • Warsaw IBD Point

    Warsaw, Poland

  • Wojskowy Instytut Medyczny - Panstwowy Instytut Badawczy, Klinika Gastroenterologii i Chorob Wewnetrznych

    Warsaw, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.